Pharmaceutical Reviews Update 6

See Pharmaceutical Reviews Update — Issue 6 for important news and information regarding CADTH’s drug review programs. Highlights from this issue:

• The latest news about CADTH’s new Patient and Community Advisory Committee.
• Updates to the fee guidance for applications to CADTH’s Pharmaceutical Review Programs.
• A summary of feedback from the August 2018 consultations on CADTH’s Pharmaceutical Review Programs.
• Last call for submissions to the 2019 Oncology Drugs in Pipeline Survey.
• A summary of the latest version of CADTH’s Common Drug Review (CDR) Procedure and Guidelines, and the Canadian Drug Expert Committee (CDEC) meeting schedule.
• An overview of the new Drug Policy Advisory Committee (DPAC) Formulary Working Group for Health Technology Assessments (FWG-HTA).
• Call for nominations for CADTH’s advisory and expert committees.